Status:
COMPLETED
A Retrospective NIS to Evaluate the Use of Seroquel XR and IR in the Clinical Practice of Outpatients With Schizophrenia
Lead Sponsor:
AstraZeneca
Conditions:
Schizophrenia
Eligibility:
All Genders
18-65 years
Brief Summary
The primary objective of this non-interventional study is to investigate how Seroquel XR and Seroquel IR are used in the clinical practice of outpatients with schizophrenia. This will be done by a ret...
Eligibility Criteria
Inclusion
- Adults with a diagnosis of schizophrenia from a district psychiatric clinic in Denmark
- Patients who have received at least one dose of Seroquel XR or Seroquel IR during January - March 2010
Exclusion
- Patients already participating in a clinical study during the study-period.
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
186 Patients enrolled
Trial Details
Trial ID
NCT01212575
Start Date
October 1 2010
End Date
February 1 2011
Last Update
March 8 2011
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Aabenraa, Aabenraa, Denmark
2
Research Site
Aarhus, Arhus, Denmark
3
Research Site
Arhus N, Arhus, Denmark
4
Research Site
Arhus S, Arhus, Denmark